Lawsuit Charges Glaxo Failed to Warn of Diabetes Drug Risk

The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack has sued the drugmaker, claiming that it failed to warn of the drug’s heart risks, according to court papers.

The claim involves rosiglitazone, which is sold under the brand names Avandia and Advandamet. Investors have been bracing for a flood of litigation against Glaxo after a widely publicized medical report last month suggested that Avandia increases the risk of heart attack and death.

Leave a Reply

Your email address will not be published. Required fields are marked *